Stay updated on Talazoparib in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talazoparib in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer site revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-15T15:29:02.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-08T15:28:04.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previous EMBRACA trial details.
    Difference
    16%
    Check dated 2026-09-24T19:42:37.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0, indicating a newer site build. This reflects an underlying update to the page's code or assets rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-09-17T20:48:39.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel was added to the EMBRACA study locations. Qiryat Krinitzi, Israel was removed from the locations list.
    Difference
    0.1%
    Check dated 2026-09-10T18:21:40.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel, 5265601 was removed and Qiryat Krinitzi, Israel, 5265601 was added to the study's locations list. The page revision was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-03T17:23:18.000Z thumbnail image

Stay in the know with updates to Talazoparib in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.